プレシジョンメディシン市場：テクノロジー、アプリケーション、エンドユーザー、デプロイメント別-2025-2030年の世界予測

プレシジョンメディシン市場は、2023年に681億2,000万米ドルと評価され、2024年には757億米ドルに達すると予測され、CAGR 11.22％で成長し、2030年には1,434億3,000万米ドルに達すると予測されています。

プレシジョンメディシンでは、遺伝学、環境的側面、ライフスタイルなどの要因を考慮し、患者一人ひとりの特性に合わせた治療を行う。このアプローチは、より個別化された効果的なヘルスケアソリューションを可能にすることで、医療行為を再構築しています。プレシジョンメディシンの必要性は、患者の転帰を改善し、医療コストを削減する可能性があることで、がん、心血管疾患、遺伝性疾患などの疾病管理における個別化治療計画のニーズの高まりに対応しています。プレシジョンメディシンの応用範囲は、ゲノミクス、デジタルヘルス技術、バイオマーカー分析に及び、医薬品開発、疾病の早期発見、治療法の選択において極めて重要です。最終用途の範囲は広く、バイオ医薬品、診断会社、ヘルスケアプロバイダーなどのセクターに影響を与えています。成長要因としては、ゲノミクスの進歩、研究開発投資の増加、標的治療の重視の高まりなどが挙げられます。さらに、政府の支援とバイオテクノロジー企業と学術機関の連携が市場拡大を後押ししています。新たなビジネスチャンスは、AIを活用したゲノム解析と、予測結果を強化するためのビッグデータの統合にあります。こうした機会を捉えようとする企業にとっては、データ分析への投資と革新的ソリューションのためのパートナーシップの構築が重要になります。しかし、開発コストの高さ、データプライバシーへの懸念、規制上のハードルなど、成長を阻害しかねない課題もあります。また、ヘルスケアプロバイダーや患者の認識や受容が限定的であることも大きな障壁となっています。イノベーションに最適な分野としては、費用対効果の高いゲノム技術の開発と精密診断の進歩が挙げられます。患者へのアクセシビリティとエンゲージメントを促進する新たなビジネスモデルを模索することで、さらなる成長が期待できます。市場は本質的にダイナミックであり、急速な技術進歩が利害関係者の機敏さと先見性を必要とします。企業は、個別化ヘルスケアの微妙な需要に対応しながら競争力を維持するために、最先端技術の統合とスケーラブルなソリューションの創造に注力すべきです。

市場力学：急速に進化するプレシジョンメディシン市場の主要市場インサイトを公開

プレシジョンメディシン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 政府資金の増加とオンライン共同フォーラムの増加
  • プレシジョンメディシンにおける人工知能の利用の増加
  • 新興企業の活発な参入によるがん生物学の進歩
• 市場抑制要因
  • プレシジョンメディシンに基づく治療の償還不足
• 市場機会
  • プレシジョンメディシンにおけるクラウドベースソリューションの採用拡大
  • 遺伝子の特徴を明らかにするための製薬会社とソフトウェア会社の戦略的提携
• 市場の課題
  • 複雑なFDA薬物療法承認率

ポーターのファイブフォース：プレシジョンメディシン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：プレシジョンメディシン市場における外部からの影響の把握

外部マクロ環境要因は、プレシジョンメディシン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析プレシジョンメディシン市場における競合情勢の把握

プレシジョンメディシン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスプレシジョンメディシン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、プレシジョンメディシン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨プレシジョンメディシン市場における成功への道筋を描く

プレシジョンメディシン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 政府資金の増加とオンライン共同フォーラムの増加
    • プレシジョンメディシンにおける人工知能の利用増加
    • がん生物学の進歩はスタートアップ企業の活発な存在によって補完されている
  • 抑制要因
    • 精密医療に基づく治療に対する補償の欠如
  • 機会
    • プレシジョンメディシンにおけるクラウドベースのソリューションの採用拡大
    • 遺伝子を特徴づけるための製薬会社とソフトウェア会社の戦略的提携
  • 課題
    • 複雑なFDA薬物療法承認率
• 市場セグメンテーション分析
  • テクノロジー：ビッグデータ分析はプレシジョンメディシンの分野を進歩させています
  • アプリケーション：プレシジョンメディシンを使用したパーソナライズされたがんおよび腫瘍学ケア
  • エンドユーザー：バイオテクノロジーおよび診断企業による研究開発への投資とプレシジョンメディシン分野の発展に向けた取り組み
  • 展開：AIとクラウドソリューションを統合し、プレシジョンメディシンサービスの開発効率とスピードを向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 プレシジョンメディシン市場：技術別

• ビッグデータ分析
• バイオインフォマティクス
• コンパニオン診断
• 創薬
• 遺伝子配列解析

第7章 プレシジョンメディシン市場：用途別

• 中枢神経系
• 免疫学
• 腫瘍学
• 呼吸器

第8章 プレシジョンメディシン市場：エンドユーザー別

• バイオテクノロジーおよび診断企業
• 研究所・製薬
• 研究センターおよび政府機関

第9章 プレシジョンメディシン市場：展開別

• クラウド上
• オンプレミス

第10章 南北アメリカのプレシジョンメディシン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のプレシジョンメディシン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのプレシジョンメディシン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ティロナ、プレシジョンメディシンの画期的なイノベーションの導入を加速するため750万ユーロの新規資金調達を実施
  • ノバルティス、プレシジョンメディシン開発会社チヌークの買収を完了
  • ダートマス大学の新センターがAIを活用して健康成果を向上
• 戦略分析と提言

企業一覧

• AccessDX Holdings
• Adaptive Biotechnologies Corporation
• Biocrates Life Sciences AG
• bioMerieux SA
• Caris Life Sciences
• Exact Sciences Corporation
• F. Hoffmann-La Roche AG
• Foundation Medicine, Inc.
• Guardant Health, Inc.
• healthOme
• Illumina, Inc.
• Intomics by ZS Associates, Inc.
• Invitae Corporation.
• Laboratory Corporation of America Holdings
• Medtronic PLC
• Natera Inc.
• Novartis AG
• Pfizer Inc.
• Precision Medicine Group, LLC
• QIAGEN GmbH
• Quest Diagnostics Incorporated
• Strata Oncology, Inc.
• Syapse, Inc.
• Tempus Labs, Inc.
• Teva Pharmaceutical Industries Ltd.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. PRECISION MEDICINE MARKET RESEARCH PROCESS
• FIGURE 2. PRECISION MEDICINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PRECISION MEDICINE MARKET DYNAMICS
• TABLE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PRECISION MEDICINE MARKET SIZE, BY CNS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY & DIAGNOSTIC COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. CHINA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. ITALY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. POLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. QATAR PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 193. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

The Precision Medicine Market was valued at USD 68.12 billion in 2023, expected to reach USD 75.70 billion in 2024, and is projected to grow at a CAGR of 11.22%, to USD 143.43 billion by 2030.

Precision medicine involves tailoring medical treatment to the individual characteristics of each patient, considering factors like genetics, environmental aspects, and lifestyle. This approach is reshaping medical practices by allowing more personalized and effective healthcare solutions. The necessity for precision medicine is underscored by its potential to improve patient outcomes and reduce healthcare costs, catering to the heightened need for personalized treatment plans in managing diseases like cancer, cardiovascular conditions, and genetic disorders. In terms of application, precision medicine spans genomics, digital health technologies, and biomarker analysis, making it pivotal in drug development, early detection of diseases, and therapy selection. The end-use scope is broad, affecting sectors such as biopharmaceuticals, diagnostic companies, and healthcare providers. Influencing growth factors include advancements in genomics, increased R&D investments, and a growing emphasis on targeted therapies. Moreover, governmental support, combined with collaborations between biotech firms and academic institutions, is driving market expansion. Emerging opportunities lie in AI-driven genomic analytics and the integration of big data to enhance predictive outcomes. For businesses aiming to seize these opportunities, investing in data analytics and forging partnerships for innovative solutions will be critical. However, there are challenges like high costs of development, data privacy concerns, and regulatory hurdles that could impede growth. Limited awareness and acceptance among healthcare providers and patients also pose significant barriers. The best areas for innovation include developing cost-effective genomic technologies and advancing precision diagnostics. Exploring new business models that promote patient accessibility and engagement can unlock additional growth. The market is inherently dynamic, with rapid technological advancements necessitating agility and foresight from stakeholders. Businesses should focus on integrating cutting-edge technologies and creating scalable solutions to remain competitive while addressing the nuanced demands of personalized healthcare.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Precision Medicine Market

The Precision Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising government funding and rising online collaborative forums
  • Increasing use of artificial intelligence in precision medicine
  • Advancement in cancer biology complemented by the active presence of startups
• Market Restraints
  • Lack of reimbursement for precision medicine-based treatment
• Market Opportunities
  • Growing adoption of cloud-based solutions in precision medicine
  • Strategic alliances among pharmaceutical and software companies to characterize the genes
• Market Challenges
  • Complicated FDA pharmacotherapy approval rate

Porter's Five Forces: A Strategic Tool for Navigating the Precision Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Precision Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Precision Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Precision Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Precision Medicine Market

A detailed market share analysis in the Precision Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Precision Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Precision Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Precision Medicine Market

A strategic analysis of the Precision Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Precision Medicine Market, highlighting leading vendors and their innovative profiles. These include AccessDX Holdings, Adaptive Biotechnologies Corporation, Biocrates Life Sciences AG, bioMerieux SA, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Foundation Medicine, Inc., Guardant Health, Inc., healthOme, Illumina, Inc., Intomics by ZS Associates, Inc., Invitae Corporation., Laboratory Corporation of America Holdings, Medtronic PLC, Natera Inc., Novartis AG, Pfizer Inc., Precision Medicine Group, LLC, QIAGEN GmbH, Quest Diagnostics Incorporated, Strata Oncology, Inc., Syapse, Inc., Tempus Labs, Inc., Teva Pharmaceutical Industries Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Precision Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Big Data Analytics, Bioinformatics, Companion Diagnostics, Drug Discovery, and Gene Sequencing.
• Based on Application, market is studied across CNS, Immunology, Oncology, and Respiratory.
• Based on End-User, market is studied across Biotechnology & Diagnostic Companies, Laboratories & Pharmaceuticals, and Research Centers & Government Institutions.
• Based on Deployment, market is studied across On-Cloud and On-Premise.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising government funding and rising online collaborative forums
    • 5.1.1.2. Increasing use of artificial intelligence in precision medicine
    • 5.1.1.3. Advancement in cancer biology complemented by the active presence of startups
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of reimbursement for precision medicine-based treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adoption of cloud-based solutions in precision medicine
    • 5.1.3.2. Strategic alliances among pharmaceutical and software companies to characterize the genes
  • 5.1.4. Challenges
    • 5.1.4.1. Complicated FDA pharmacotherapy approval rate
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Big data analytics is advancing the field of precision medicine
  • 5.2.2. Application: Personalized cancer and oncology care using precision medicine
  • 5.2.3. End-user: Efforts by biotechnology and diagnostic companies to invest in R&D and advance the field of precision medicine
  • 5.2.4. Deployment: Integration of AI and cloud solutions to improve efficacy and speed of development of precision medicine services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Precision Medicine Market, by Technology

• 6.1. Introduction
• 6.2. Big Data Analytics
• 6.3. Bioinformatics
• 6.4. Companion Diagnostics
• 6.5. Drug Discovery
• 6.6. Gene Sequencing

7. Precision Medicine Market, by Application

• 7.1. Introduction
• 7.2. CNS
• 7.3. Immunology
• 7.4. Oncology
• 7.5. Respiratory

8. Precision Medicine Market, by End-User

• 8.1. Introduction
• 8.2. Biotechnology & Diagnostic Companies
• 8.3. Laboratories & Pharmaceuticals
• 8.4. Research Centers & Government Institutions

9. Precision Medicine Market, by Deployment

• 9.1. Introduction
• 9.2. On-Cloud
• 9.3. On-Premise

10. Americas Precision Medicine Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Precision Medicine Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Precision Medicine Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Thirona Raises EUR 7.5 Million New Financing to Accelerate the Adoption of its Breakthrough Innovations for Precision Medicine
  • 13.3.2. Novartis completes acquisition of precision medicine developer Chinook
  • 13.3.3. New Dartmouth Center Applies AI to Improve Health Outcomes
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AccessDX Holdings
• 2. Adaptive Biotechnologies Corporation
• 3. Biocrates Life Sciences AG
• 4. bioMerieux SA
• 5. Caris Life Sciences
• 6. Exact Sciences Corporation
• 7. F. Hoffmann-La Roche AG
• 8. Foundation Medicine, Inc.
• 9. Guardant Health, Inc.
• 10. healthOme
• 11. Illumina, Inc.
• 12. Intomics by ZS Associates, Inc.
• 13. Invitae Corporation.
• 14. Laboratory Corporation of America Holdings
• 15. Medtronic PLC
• 16. Natera Inc.
• 17. Novartis AG
• 18. Pfizer Inc.
• 19. Precision Medicine Group, LLC
• 20. QIAGEN GmbH
• 21. Quest Diagnostics Incorporated
• 22. Strata Oncology, Inc.
• 23. Syapse, Inc.
• 24. Tempus Labs, Inc.
• 25. Teva Pharmaceutical Industries Ltd.
• 26. Thermo Fisher Scientific Inc.